Oppenheimer Cuts Cogent to Neutral

Analyst Joshua Zaret says the company's 2006 outlook was disappointing

Oppenheimer downgraded Cogent (COGT) to neutral from buy, after the biometric services company on Tuesday announced quarterly results.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.